Relative Eye Size in ElasmobranchsLisney T.J. · Collin S.P.
School of Biomedical Sciences, Vision Touch and Hearing Research Centre, The University of Queensland, Brisbane, Australia
Do you have an account?
- Rent for 48h to view
- Buy Cloud Access for unlimited viewing via different devices
- Synchronizing in the ReadCube Cloud
- Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00
Article / Publication Details
Variation in relative eye size was investigated in a sample of 46 species of elasmobranch, 32 species of sharks and 14 species of batoids (skates and rays). To get a measure of eye size relative to body size, eye axial diameter was scaled with body mass using least-squares linear regression, using both raw species data, where species are treated as independent data points, and phylogenetically independent contrasts. Residual values calculated for each species, using the regression equations describing these scaling relationships, were then used as a measure of relative eye size. Relative and absolute eye size varies considerably in elasmobranchs, although sharks have significantly relatively larger eyes than batoids. The sharks with the relatively largest eyes are oceanic species; either pelagic sharks that move between the epipelagic (0–200 m) and ‘upper’ mesopelagic (200–600 m) zones, or benthic and benthopelagic species that live in the mesopelagic (200–1,000 m) and, to a lesser extent, bathypelagic (1,000–4,000 m) zones. The elasmobranchs with the relatively smallest eyes tend to be coastal, often benthic, batoids and sharks. Active benthopelagic and pelagic species, which prey on active, mobile prey also have relatively larger eyes than more sluggish, benthic elasmobranchs that feed on more sedentary prey such as benthic invertebrates. A significant positive correlation was found between absolute eye size and relative eye size, but some very large sharks, such as Carcharodon carcharias have absolutely large eyes, but have relatively small eyes in relation to body mass.
© 2007 S. Karger AG, Basel
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.